You can Submit Your Abstract or Apply for a Congress Attendance Grant to FEMS2023 until the deadline Wednesday 1 February. Reconnect with thousands of scientists from the microbiology community: combine, change, convene, continue, converse, create, and cross borders!

Taking place from 9 – 13 July 2023, make sure you take the opportunity to present your research at the 10th European Congress of Microbiologists in Hamburg, Germany.

View the programme day by day or at a glance, explore the session formats, and find out which sessions are inviting abstracts.

Main topics

  • Environmental Microbiology & Ecology
  • Biotechnology & Synthetic Microbiology
  • Food Microbiology
  • Infection Biology and Pathogens
  • Infectious Diseases
  • Taxonomy and systematics
  • Genetics/genomics
  • Virology
  • Microbiology Education & Profession
  • Molecular Microbiology and Biochemistry

Join us at FEMS2023!


 

 

New ÖGMBT company member

Thursday, 12 January 2023 10:51

We are happy to welcome our new company member: CYTIVA

We are a global provider of technologies and services that advance and accelerate the development, manufacture, and delivery of therapeutics. Our rich heritage dates back hundreds of years, and we got a fresh start in 2020 as a standalone operating company in the Danaher Corporation.

Homepage:     www.cytiva.com

 

New ÖGMBT company member

Wednesday, 11 January 2023 11:29

We welcome our new company member:

acib is an international center of excellence in the field of industrial biotechnology. The research center develops sustainable, environmentally friendly, and economically and technically advanced processes for the biotech-, pharmaceutical- and chemical industries. In doing so, it takes nature’s methods and tools as its model. Within its partner network, acib cooperates with industry in order to transfer scientific results into efficient processes and innovative products, always for the benefit of humans, animals and the environment.

Homepage:         https://acib.at/

 

Die nächste Ausschreibungsrunde in Horizon Europe startet in Kürze mit einem Volumen von rund 5,5 Milliarden Euro an Förderungen. Die Europäische Kommission hat bereits vorläufige Versionen des Horizon Europe Arbeitsprogramms 2023/24 veröffentlicht (Änderungen noch möglich).
Bisher vorliegende Entwürfe und Veranstaltungen zu den kommenden Ausschreibungen: 

Für mehr Informationen: https://ec.europa.eu/info/funding-tenders/opportunities/portal/screen/home

 

About The International Microbiology Literacy Initiative (IMiLI)

Microbes and their activities have pervasive, remarkably profound and generally positive effects on the functioning, and thus health and well-being, of human beings, the whole of the biological world, and indeed the entire surface of the planet and its atmosphere. This necessitates their due consideration in decisions that are taken by individuals and families in everyday life, as well as by individuals and responsible bodies at all levels and stages of community, national and international planetary health assessment, planning, and the formulation of pertinent policies.  

However, knowledge of societally-relevant microbial activities, how they impact our lives, and how they may be harnessed for the benefit of humankind – microbiology literacy – is lacking in the general population, and in the subsets thereof that constitute the decision makers. The IMiLI contends that microbiology literacy in society is indispensable for informed personal decisions, policy development in government and business, and for knowledgeable input of societal stakeholders in such policymaking. An understanding of key microbial activities is as essential for transitioning from childhood to adulthood as some subjects currently taught at school, and must therefore be acquired during general education. The IMiLI is creating resources for a school curriculum of societally-relevant microbiology and calls upon microbiologists, microbiological learned societies and microbiology‐literate professionals to help develop child‐friendly, appealing teaching tools and materials, and convince educators, policy makers, business leaders and governmental and non‐governmental agencies to support and promote adoption of the curriculum by education authorities worldwide.

About FEMS

The Federation of European Microbiological Societies (FEMS) is a not-for-profit organization, established in 1974 to advance microbiology for the benefit of society in the areas of health, energy, food, materials, and the environment. We are committed to supporting microbiologists do their work; promoting the best in microbiology research and knowledge to the world and, bringing microbiologists together to share that knowledge. We reinvest our revenues into supporting microbiologists throughout their career, publishing and promoting scientific research in our journals and organizing events to bring scientists together.

About FEMS Lwoff Award for Achievements in Microbiology

Launched in 2000, the FEMS-Lwoff Award for Achievements in Microbiology rewards those that create high quality knowledge that helps to solve today’s societal problems around microbiology. It was named in honour of the 1st FEMS President (1974-1976), Professor André M. Lwoff. Previous winners include Prof Miroslav Radman and Prof Emmanuelle Charpentier.

 

Invitation to participate in an open consultation for the Strategic Research and Innovation Agenda (SRIA) in support for the European Partnership for Personalised Medicine, EP PerMed

It is our pleasure to inform you that the open consultation to validate and receive input for the Strategic Research and Innovation Agenda (SRIA) in support for the European Partnership for Personalised Medicine, EP PerMed, is launched. The outcome of the online consultation will be considered for the SRIA finalisation (02/2023) and the EP PerMed proposal (04/2023) as well as for developing activities and calls within the EP PerMed lifetime (Q4/2023-2030).

In preparation of the open consultation, the drafting group, with support of the European Commission, conducted almost 70 interviews with diverse stakeholders. Based on the interviews and consultation of strategic documents, a first set of 47 “Triplets of Action” was identified (further defined below). This list represents a first summary, adapted to a common format, but is not exhaustive and open for further input and refinement.

In a pre-final step (November 2022), the drafting group performs now an online consultation for the following purposes:

  • Communication of the SRIA in general and the identified “Triplets of Action” in specific,
  • To obtain general input, especially related to the “Triplets of Action”,
  • Input regarding the urgency and timing of the “Triplets of Action”,
  • To obtain suggestions for additional “Triplets of Action”.

The questionnaire will take around 30 min to be completed. The open consultation will close on 21 December 2022 and can be accessed through this link: http://enquetes.agencerecherche.fr/index.php/survey/index/sid/976696/lang/en

 

More information is available on the ICPerMed (https://www.icpermed.eu/en/EP-PerMed-SRIA-Consultation.php) and ERA PerMed websites and provided at the end of this email.

We would be pleased about your participation in this open consultation.

Please share this information with your colleagues and other stakeholders that might contribute with their expertise to the EP PerMed SRIA.

For any question you might have regarding the EP PerMed and the SRIA, please contact This email address is being protected from spambots. You need JavaScript enabled to view it..

 

Background information:

European Partnership for Personalised Medicine (EP PerMed)

The EP PerMed is one of the European research and innovation partnerships under Horizon Europe which will be dedicated to maximising the benefits of personalised medicine (PM) approaches. The European Commission and Member States have made large investments in personalised medicine over the years and this partnership builds on many of these investments. The core of the partnership is to invest in multidisciplinary, transnational research (basic, clinical, and translational) and innovation activities that will build and disseminate new knowledge, develop new technologies and methods, as well as supporting testing and piloting of the implementation of PM approaches. The partnership will work in close collaboration with other health partnerships and reach out to national, regional, and international initiatives and frameworks to ensure synergies and investments of scale. In addition, the partnership will include supportive activities contributing to policy, regulation and strengthening the field of health economics. Early this year, a draft proposal was published. At present the consortium is formed to draft the proposal for submission to the EC in April 2023. The investments from both Member States and the Commission for the 7-10 years duration of the partnership is expected to be over 300 Mio. Euros.

The EP PerMed Strategic Research and Innovation Agenda (SRIA), which is currently in preparation will guide the funding and supporting activities.

Strategic Research and Innovation Agenda (SRIA) to support the EP PerMed

All European Partnerships (EP) develop a SRIA before their launch to ensure that their long-term vision is translated into tailored roadmaps with activities, objectives and measurable outcomes.

The EP PerMed SRIA presents gaps, needs and challenges which should be addressed to maximise the benefits of Personalised Medicine approaches and ensure that there is an equal access to these approaches. The SRIA is divided into four areas of activities, “interdisciplinary research including basic, translational and clinical”, “innovation system” and “implementation” as well as “Overarching activities”. The consortium together with international experts and stakeholders have collected input and analysed reports. The drafting group, with kind support of the European Commission, organised almost 70 interviews with a diverse set of stakeholders. The interviews were translated into Triplets of Action (further explained below), where applicable.

A key element of the SRIA are the so-called Triplets of Action (challenge/objective/outcome) related to personalised medicine. The challenge/objective/outcome sequence allows to specify gaps, needs and actions in a structured and comparable way, following this definition:

Challenge:           Description of the status quo, indicate/indication what is still lacking, why this is the case and what negative consequences this has.

Objectives:          Indicates what exactly should be done to address the challenge in terms of specific actions.

Outcome:            Description of how the situation will have improved once the actions described in the objectives have been successfully implemented. 

The Triplets of Action will give an overview of needs and gaps and guide the prioritisation of challenges and subsequent actions. So far, over the different areas and chapters of the SRIA a total of 47 Triplets of Action were identified. This list is not exhaustive and open for further input and refinement.

By taking part in the open consultation launched in November 2022, participants can share their view on future activities and research for accelerating the implementation of personalised medicine approaches. Input from the whole spectrum of stakeholders and experts involved in the personalised medicine areas is encouraged, such as scientists, healthcare professionals, patients, citizens, policy advisors or individuals working in the pharma industry and biotech.

ISIDORe preparedness calls for proposals

Monday, 28 November 2022 11:12

ISIDORe preparedness calls for proposals

Following its rapid research response calls for proposals dedicated to SARS-CoV-2  (still open) and Monkeypox virus (Pre-application deadline: 29 November 2022), ISIDORe (Integrated Services for Infectious Disease Outbreak Research) has launched its preparedness programme calls for proposals for free of charge access to the consortium facilities and services.

To prevent future pandemics, and advance the development of the appropriate medical countermeasures, the ISIDORe preparedness programme includes a list of priority preparedness pathogens clustered in four calls for proposals to support research on the epidemic-prone pathogens such as Risk-Group 4 pathogens (Ebola virus, Marburg virus, Nipah virus, Hendra virus, Lassa virus, “New world arenaviruses”, CCHF virus); Respiratory Pathogens (zoonotic betacoronaviruses, Influenza A, Y. Pestis, M. Tuberculosis/bovis, C. burnetii ); Vector-borne Pathogens (Rift valley fever virus, Zika virus, Chikungunya virus, West Nile virus, Dengue virus, Japanese encephalitis virus, Yellow fever virus, Tick-borne encephalitis virus, Plasmodium, B. burgdorferi, Leishmania); and other pathogens with epidemic potential (pathogen X, Orthopoxviruses, Non polio enteroviruses, Polio enteroviruses).

More information about the calls and how to apply can be found here

 

ISIDORe Information webinar

29 November, 2022, 10AM CET

The ISIDORe coordination team is pleased to invite you to the Information Webinar dedicated to the Preparedness calls for proposals (RG4 pathogens, Respiratory pathogens, Vector-borne pathogens, Pathogen X) launched in November 2022. It aims to provide you with information about the calls and application modalities, as well as to answer your questions.

Register here

More information can be found here


 

 

The International Union of Pure and Applied Chemistry is the global organization that provides objective scientific expertise and develops the essential tools for the application and communication of chemical knowledge for the benefit of humankind and the world. In 2019 IUPAC entered its second century, providing an opportunity to launch initiatives to create a more diverse and inclusive community. This webinar offers an overview, some insights and progress on this journey, with a focus on gender issues.

The event will be held online on October 26th, 2022 at 2-4 PM CEST.

More infos on the webinar and registration form: https://gender-equality-in-science.org/event/scges-webinar-october-26th-2022/

 

Participants in the webinar:

Laura McConnell, Bayer Crop Science, Bayer Science Fellow, Regulatory Scientific Affairs, United States
“Building A Global Network”

Mary Garson, Professor, School of Chemistry and Molecular Biosciences, The University of Queensland, Australia
“Expanding the Role of Women in IUPAC”

Mei-Hung Chiu, Professor, National Taiwan Normal University, Graduate Institute of Science Education
“Nurturing a more inclusive STEM Community”

Discussion moderated by Mark Cesa, President of IUPAC, 2014-15.

 

New ÖGMBT company member

Monday, 03 October 2022 02:01

We welcome our new ÖGMBT Company Member: Ludwig Boltzmann Gesellschaft Career Center (LBG-CC)

 

 LBG Career Center – We care for Pre- & Post-Docs

We support (young) researchers in Austria in achieving their individual career goals – in or outside of academia. Contact us for a career chat, join our workshops or special programs and design your own unique career path! We empower you to enhance your knowledge and skills for your next career steps and to expand your network. Apply for our next program “Digital Transformation for Researchers” until October 16 and dive deeper into the world of Digitization & Data Science.

 

CYTIVA virtual half-day forum

Thursday, 29 September 2022 04:22

Half-day virtual event from Cytiva: How biotech startups and translational researchers can prepare to bring innovative treatments to patients

Cytiva has invited several noteworthy colleagues from our industry to share their experience in an intimate online forum.

Join guests from THT Biomaterials (Vienna, AT), Charité (Berlin, DE), Prime Vector Technologies (Tübingen, DE), and a few Cytiva mentors who will discuss the challenges, triumphs, and key considerations for the development and delivery of novel therapies to patients.

In this virtual half-day forum, Cytiva invites industry leaders to share their experiences with overcoming obstacles and bringing novel therapies to patients. Join for guidance on what to expect on the translational journey along with how to avoid common pitfalls as you get started.
 
The program will be presented in two sessions with a 20-minute intermission. It will end with a roundtable discussion where you will have the chance to ask the experts your questions on how best to bridge basic research and clinical trials

When: Tuesday, 18 Oct, from 14:00 – 18:00 pm

More details: registration page - sign up and participate.

Even if your schedule conflicts, you are encouraged to register, as you will be sent a recording after the event.

Page 1 of 2
  • FEMS2023 - Submit your Abstract & Grant Application to FEMS2023 by 1 February
    You can Submit Your Abstract or Apply for a Congress Attendance Grant to FEMS2023 until the deadline Wednesday 1 February. Reconnect with thousands of scientists from the microbiology community: combine, change, convene, continue, converse, create, and cross borders! Taking place from 9 – 13 July 2023, make sure you take the opportunity to present your research at the 10th European Congress of Microbiologists in Hamburg, Germany. View the programme day by day or at…
    26.01.2023,
  • FEMS - Get Involved bulletin – December 2022
    The new FEMS Get involved bulletin is out! Read the December issue with microbiology research, events and calls.   In this bulletin: #FEMSmicroBlog FEMS Journals Opportunities Board FEMS Grants   Deadlines: Research and Training Grants: 1 January 2023 Industry Placement Grants: 1 February 2023 Meeting Attendance Grants: 1 March 2023   The ÖGMBT has a very wide international network and is a member of several relevant scientific societies like FEMS.…
    23.12.2022,
  • EFB Newsletter December
    The new EFB Newsletter is out! Read the December issue with microbiology research, events and calls.   The ÖGMBT has a very wide international network and is a member of several relevant scientific societies like EFB. ÖGMBT members are automatically members of these societies and are entitled to benefits such as travel grants, short-term and long-term fellowships, Awards etc. Current calls and deadlines are published on our webpage and are…
    23.12.2022,
  • FEMS Affiliates Letter - December 2022
    As member of the ÖGMBT you are automatically also member of the Federation of European Microbiology Societies (FEMS). The FEMS Affiliates Letter of December 2022 has the following content: 1. Microbiology News and Events 2. FEMS Research 3. Policy Corner 4. Grants Corner 5. Opportunities 6. Extras     Important Dates: 3 October 2022: Abstract & Grants Submission open 1 January 2023: Registration Opens 1 February 2023: Abstract & Grants Submission deadline    
    19.12.2022,
  • 2023 FEMS-Lwoff Award for Achievements in Microbiology
    The 2023 FEMS-Lwoff Award for Achievements in Microbiology has been awarded to Professor Kenneth Timmis of the Technical University of Braunschweig in Germany. Kenneth Timmis was selected for the award for his contributions to the field of environmental microbiology and advocacy of microbiology literacy. He is the lead author of the paper ‘The urgent need for microbiology literacy in society’ and created and leads the International Microbiology Literacy Initiative, coining…
    12.12.2022,
  • Horizon Europe: Neue Ausschreibungen in Vorbereitung
    Die nächste Ausschreibungsrunde in Horizon Europe startet in Kürze mit einem Volumen von rund 5,5 Milliarden Euro an Förderungen. Die Europäische Kommission hat bereits vorläufige Versionen des Horizon Europe Arbeitsprogramms 2023/24 veröffentlicht (Änderungen noch möglich). Bisher vorliegende Entwürfe und Veranstaltungen zu den kommenden Ausschreibungen:  Cluster 1 Gesundheit: Infotag 19. Jänner, Brokerage Event 20. Jänner Cluster 2 Kultur, Kreativität und Inklusive Gesellschaft: Infotag 17. Jänner, Brokerage Event 18. Jänner Cluster 4…
    12.12.2022,
  • FEBS Network News November
    The ÖGMBT has a very wide international network and is a member of several relevant scientific societies like FEBS. ÖGMBT members are automatically members of these societies and are entitled to benefits such as travel grants, short-term and long-term fellowships, Awards etc. Current calls and deadlines are published on our webpage and are sent to our members within the ÖGMBT newsletter.   ÖGMBT-YLSA (Young Life Scientists Austria) Young Life Scientists…
    29.11.2022,
  • FEMS - Get Involved bulletin – November 2022
    The new FEMS Get involved bulletin is out! Read the November issue with microbiology research, events and calls.   In this bulletin: FEMS Congress 9-13 July, 2023 in Hamburg, Germany #FEMSmicroBlog FEMS Journals Opportunities Board FEMS Grants   Deadlines: Meeting Organizer Grants: 1 December 2022 Research and Training Grants: 1 January 2023 Industry Placement Grants: 1 February 2023 Meeting Attendance Grants: 1 March 2023   The ÖGMBT has a very…
    29.11.2022,
  • Invitation to participate: open consultation for Strategic Research & Innovation Agenda (SRIA)
    Invitation to participate in an open consultation for the Strategic Research and Innovation Agenda (SRIA) in support for the European Partnership for Personalised Medicine, EP PerMed It is our pleasure to inform you that the open consultation to validate and receive input for the Strategic Research and Innovation Agenda (SRIA) in support for the European Partnership for Personalised Medicine, EP PerMed, is launched. The outcome of the online consultation will…
    28.11.2022,
  • ISIDORe preparedness calls for proposals
    ISIDORe preparedness calls for proposals Following its rapid research response calls for proposals dedicated to SARS-CoV-2  (still open) and Monkeypox virus (Pre-application deadline: 29 November 2022), ISIDORe (Integrated Services for Infectious Disease Outbreak Research) has launched its preparedness programme calls for proposals for free of charge access to the consortium facilities and services. To prevent future pandemics, and advance the development of the appropriate medical countermeasures, the ISIDORe preparedness programme…
    28.11.2022,
  • LISAvienna: Collaboration opportunities with Boehringer Ingelheim, Roche and Takeda
    Did you know that LISAvienna collaborates with global players and connects them with regional innovators and start-ups? Here we provide some information on new opportunities: Boehringer Ingelheim Office Hours, March 7, 2023: A pioneering mentoring initiative that provides access to big pharma expertise and feedback from an industry perspective! Apply for 1 of 5-6 meeting slots by February 10 https://www.lisavienna.at/events/detail/lisavienna-event-tip-boehringer-ingelheim-office-hours-on-march-7-2023-1/   Takeda R&D Science Day, Vienna, April 19, 2023: Present your innovative technologies and analytical…
    13.01.2023,
    by
  • LISAvienna: Collaboration opportunities with Boehringer Ingelheim, Roche and Takeda
    Did you know that LISAvienna collaborates with global players and connects them with regional innovators and start-ups? Here we provide some information on new opportunities: Boehringer Ingelheim Office Hours, March 7, 2023: A pioneering mentoring initiative that provides access to big pharma expertise and feedback from an industry perspective! Apply for 1 of 5-6 meeting slots by February 10 https://www.lisavienna.at/events/detail/lisavienna-event-tip-boehringer-ingelheim-office-hours-on-march-7-2023-1/   Takeda R&D Science Day, Vienna, April 19, 2023: Present your innovative technologies and analytical…
    13.01.2023,
    by
  • LISAvienna: Collaboration opportunities with Boehringer Ingelheim, Roche and Takeda
    Did you know that LISAvienna collaborates with global players and connects them with regional innovators and start-ups? Here we provide some information on new opportunities: Boehringer Ingelheim Office Hours, March 7, 2023: A pioneering mentoring initiative that provides access to big pharma expertise and feedback from an industry perspective! Apply for 1 of 5-6 meeting slots by February 10 https://www.lisavienna.at/events/detail/lisavienna-event-tip-boehringer-ingelheim-office-hours-on-march-7-2023-1/   Takeda R&D Science Day, Vienna, April 19, 2023: Present your innovative technologies and analytical…
    13.01.2023,
  • New ÖGMBT company member
    We are happy to welcome our new company member: CYTIVA We are a global provider of technologies and services that advance and accelerate the development, manufacture, and delivery of therapeutics. Our rich heritage dates back hundreds of years, and we got a fresh start in 2020 as a standalone operating company in the Danaher Corporation. Homepage:     www.cytiva.com  
    12.01.2023,
    by
  • New ÖGMBT company member
    We welcome our new company member: acib is an international center of excellence in the field of industrial biotechnology. The research center develops sustainable, environmentally friendly, and economically and technically advanced processes for the biotech-, pharmaceutical- and chemical industries. In doing so, it takes nature’s methods and tools as its model. Within its partner network, acib cooperates with industry in order to transfer scientific results into efficient processes and innovative…
    11.01.2023,
    by
  • New ÖGMBT company member
    We welcome our new ÖGMBT Company Member: Ludwig Boltzmann Gesellschaft Career Center (LBG-CC)    LBG Career Center – We care for Pre- & Post-Docs We support (young) researchers in Austria in achieving their individual career goals – in or outside of academia. Contact us for a career chat, join our workshops or special programs and design your own unique career path! We empower you to enhance your knowledge and skills…
    03.10.2022,
    by
  • New ÖGMBT company members
    We welcome our new ÖGMBT Company Members: PHIO scientific GmbH, The Core Facilities of the University of Natural Resources and Life Sciences (BOKU), Ribbon Biolabs, VALIDOGEN, DirectSens, The Doctoral School in Microbiology and Ecosystem Science       PHIO scientific GmbH is a high tech company from Munich, one of th e leading biotech-hubs in Europe. Our fully automatic, super compact microscopes and cutting-edge AI analysis platform allow for continuous imaging…
    08.09.2022,
    by
  • Erklärvideo zu Totimpfstoffen gegen COVID-19
    Das neue Erklärvideo von Open Science "SARS-CoV-2: Totimpfstoffe" ist fertig - rechtzeitig zum Start der Impfung mit dem Proteinimpfstoff von Novavax! Das Video, das in Kooperation mit dem Doktoratskolleg RNA-Biologie und der FH Campus Wien entstanden ist, erklärt, wie inaktivierte Ganzvirus- und Proteinimpfstoffe gegen COVID-19 hergestellt werden, was sie beinhalten und wie sie wirken.    
    02.03.2022,
  • Labbuddy - Training lab teaching
    We developed a training on teaching in the lab, in which we will provide teachers with tips and tricks that will help them inspire student learning in the lab. Laboratory course teaching fundamentals Teaching seems easy…….. ………until the moment you need to teach! Teaching is a true profession, but everyone can learn how to teach. Do you need to teach because of your Ph.D. study, or are you a teacher…
    27.01.2022,
    by
  • Open Call for Applications: 4 Fellowships 4 Entrepreneurs 2022
    Do you have an entrepreneurial idea that you want to develop under the guidance of experts? Are you ready to sound out your entrepreneurial spirit? Then the LBG Career Center might have the right program for you! Within the 4 Fellowships 4 Entrepreneurs program, you will build foundational knowledge about entrepreneurship, receive support on your journey to launching your ideas, and start on the path to becoming an entrepreneur.Throughout 9 months,…
    18.01.2022,
    by
  • Projektingenieur:in Pharma
    Projektingenieur:in Pharma NOTCHDELTADer Beitrag Projektingenieur:in Pharma erschien zuerst auf Jobbörse und Netzwerk für Naturwissenschaftler /-innen....
    28.01.2023,
  • Die Erde bebt
    Das Erdbeben von 1348, das damals zum Sturz des Dobratsch’s führte, war das stärkste Erdbeben in Kärnten seit 11.500 Jahren. Ein Geologen-Team der Universität Innsbruck untersuchte die Sedimente der Kärntner Seen auf Spuren vergangener Erdbeben. Die Ergebnisse zeigen, dass das Erdbeben von 1348 die stärksten Erschütterungen im Kärntner Raum s...
    26.01.2023,
  • Neue Forschungs- und Behandlungsschwerpunkte im Fokus
    Mit Wirkung vom 01. Jänner 2023 wurde Univ.-Prof. Dr. Robert Sucher für das Fach „Allgemeinchirurgie und Viszeralchirurgie“ an die Medizinische Universität Graz berufen und mit der Leitung der Klinischen Abteilung für Allgemein-, Viszeral- und Transplantationschirurgie (AVT) betraut. Internationale ErfahrungDer 43-jährige Kärntner ist durch seine l...
    25.01.2023,
  • Research Associate
    A Research Associate is responsible for assisting with scientific research and experimentation in a laboratory or research setting. The specific tasks and responsibilities of a Research Associate may vary depending on the industry or organization they work for, but they typically involve conducting laboratory experiments, collecting and analyzing...
    23.01.2023,
  • Politik – so alt wie die Menschheit selbst
    Wie lebensbedrohlich falsche Entscheidungen und Fehlverhalten in der Politik sein können, wird uns aktuell täglich über die Medien vor Augen geführt. Politik und die Ausübung von Macht sind so alt wie die Menschheit selbst. Sie regeln das Zusammenleben. Daher ist der verantwortungsvolle Umgang mit Politik von allen Seiten, von Politikern selbst, de...
    19.01.2023,
  • Das Rektorat an Uni Innsbruck ist startklar
    Der Universitätsrat der Universität Innsbruck hat in seiner Sitzung am 12. Jänner die von der designierten Rektorin Univ.-Prof. Dr. Veronika Sexl vorgeschlagenen vier Vizerektor*innen bestellt. Gemeinsam mit ihr werden diese ihr Amt am 1. März 2023 antreten.Nachhaltigkeit & Digitalisierung, Finanzen & Infrastruktur neuVeronika Sexl hatte...
    17.01.2023,
  • B-Vitamine für “geschmeidige” Gefäße
    B-Vitamine sind wahre Allrounder: Sie tragen wesentlich zu reibungslosen Stoffwechselprozessen bei, sorgen für Hormon- und Blutbildung sowie gesunde Nerven. Grazer Forscher*innen haben nun herausgefunden, dass B-Vitamine auch unsere Blutgefäße „geschmeidig“ halten.Hoher Cholesterinspiegel trifft B-Vitamin-DefizitBislang galt ein hoher...
    17.01.2023,
  • Technical Assistant
    A Technical Assistant provides technical support and assistance to a team or organization. The specific tasks and responsibilities of a Technical Assistant may vary depending on the industry or company they work for, but they typically involve providing support for technical processes and equipment, troubleshooting technical problems, and...
    16.01.2023,
  • Regulatory Affairs Manager
    A regulatory affairs manager is responsible for managing the regulatory process for getting a company’s products approved for sale. This may include for example the package leaflet for the approved medications, ensuring that they meet the local legislative requirements. The regulatory affairs manager ensures that the company’s products...
    12.01.2023,
  • Medical Science Liaison
    A medical science liaison (MSL), also known as a medical liaison manager, is a scientific and medical expert who serves as a link between a pharmaceutical or biotechnology company and the medical community. They are experts in communicating complex scientific and medical information to a variety of stakeholders. The medical liaison manager is...
    12.01.2023,